drugset / Trial / NCT01660945
Vascular and Metabolic Effects of Vytorin
RandomizedParallel-groupSingle-blindTreatment
Summary
The investigator hypothesize that vytorin may improve vascular and insulin resistance in hypercholesterolemic patients
Timeline
- Start
- 2011-07
- Primary completion
- 2012-07
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | vytorin | Unknown | 10 mg | — |
| Comparator | vytorin | Unknown | 20 mg | — |